 DNA repair pathways can result in the formation of tumor cells.Cancer treatments have been engineered using DNA cross-linking agents to interact with nitrogenous bases of DNA to block DNA replication.These cross-linking agents have the ability to act as single-agent therapies by targeting and destroying specific nucleotides in cancerous cells.